DaVita, Inc. (DVA)
179.25
+2.23
(+1.26%)
USD |
NYSE |
Oct 09, 16:00
179.17
-0.08
(-0.04%)
After-Hours: 20:00
DaVita Cash from Operations (Quarterly) : 490.07M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 490.07M |
| March 31, 2026 | 320.94M |
| December 31, 2025 | 540.75M |
| September 30, 2025 | 841.57M |
| June 30, 2025 | 324.39M |
| March 31, 2025 | 181.32M |
| December 31, 2024 | 547.75M |
| September 30, 2024 | 810.40M |
| June 30, 2024 | 802.57M |
| March 31, 2024 | -132.01M |
| December 31, 2023 | 486.75M |
| September 30, 2023 | 662.77M |
| June 30, 2023 | 450.74M |
| March 31, 2023 | 463.68M |
| December 31, 2022 | 345.19M |
| September 30, 2022 | 711.98M |
| June 30, 2022 | 188.70M |
| March 31, 2022 | 322.66M |
| December 31, 2021 | 531.24M |
| September 30, 2021 | 567.40M |
| June 30, 2021 | 679.89M |
| March 31, 2021 | 155.28M |
| December 31, 2020 | 487.04M |
| September 30, 2020 | 482.89M |
| June 30, 2020 | 651.42M |
| Date | Value |
|---|---|
| March 31, 2020 | 360.83M |
| December 31, 2019 | 681.82M |
| September 30, 2019 | 641.85M |
| June 30, 2019 | 609.81M |
| March 31, 2019 | 141.46M |
| December 31, 2018 | 389.46M |
| September 30, 2018 | 458.24M |
| June 30, 2018 | 562.58M |
| March 31, 2018 | 365.00M |
| December 31, 2017 | 345.04M |
| September 30, 2017 | 553.17M |
| June 30, 2017 | 149.89M |
| March 31, 2017 | 865.17M |
| December 31, 2016 | 482.18M |
| September 30, 2016 | 535.62M |
| June 30, 2016 | 516.64M |
| March 31, 2016 | 429.00M |
| December 31, 2015 | 436.74M |
| September 30, 2015 | 679.05M |
| June 30, 2015 | 31.44M |
| March 31, 2015 | 410.09M |
| December 31, 2014 | -69.60M |
| September 30, 2014 | 848.00M |
| June 30, 2014 | 262.58M |
| March 31, 2014 | 419.25M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 597.00M |
| Labcorp Holdings, Inc. | 445.50M |
| Lifestance Health Group, Inc. | 99.91M |
| Progyny, Inc. | 50.42M |
| Acadia Healthcare Co., Inc. | 162.07M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -194.55M |
| Cash from Financing (Quarterly) | -269.89M |
| Free Cash Flow | 1.610B |
| Free Cash Flow Per Share (Quarterly) | 4.846 |
| Free Cash Flow to Equity (Quarterly) | 134.62M |
| Free Cash Flow to Firm (Quarterly) | 435.78M |
| Free Cash Flow Yield | 12.83% |